冠状动脉慢血流患者血清Cys-C、hs-CRP、ET-1水平变化及其意义

doi:10.3969/j.issn.1671-7171.2020.10.025

Abstract
Figure/Table
References
Related Citation (15)

Download: PDF (0 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract 【Objective】 To investigate the changes and significance of serum cystatin C, high-sensitivity C-reactive protein (hs-CRP) and endothelin-1 (ET-1) in patients with coronary artery slow flow phenomenon (CSFP). 【Methods】 From January 2016 to December 2019, 88 CSFP patients with coronary heart disease confirmed by coronary angiography (observation group) were selected, and 90 patients with normal coronary blood flow and no obvious coronary stenosis were selected as control group. The coronary flow frame number, coronary microcirculation resistance index, serum Cys-C, hs CRP and ET-1 levels were compared between the two groups, and the correlation between serum Cys-C, hs CRP, ET-1 and coronary microcirculation resistance index was analyzed. 【Results】 The left anterior descending artery, right coronary artery, left circumflex artery and overall mean coronary blood flow frame number in the observation group were higher than those in the control group, the difference was statistically significant (P<0.05).The left anterior descending artery, right coronary artery, left circumflex artery and the total microcirculation resistance index of the observation group were higher than those of the control group, the difference was statistically significant (P<0.05).The levels of Cys-C, hs CRP and ET-1 in the observation group were higher than those in the control group (P<0.05). The levels of serum Cys-C, hs CRP and ET-1 in the observation group were significantly positively correlated with coronary microcirculation resistance index (P<0.05).【Conclusion】 The levels of serum Cys-C, hs CRP and ET-1 in CSFP patients are significantly increased, and they are significantly correlated with the increase of coronary microcirculation resistance index.

Key words： Coronary Artery Disease Chalones /BL C-Reactive Protein /BL Endothelin-1/BL

Received: 15 May 2020

PACS:

R541.4

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	MAO Hong-yan
	ZHAO Xiu-min
	QIAO Jian

Cite this article:

MAO Hong-yan,ZHAO Xiu-min,QIAO Jian. Changes and Significance of Serum Cys-C, hs CRP and ET-1 in Patients with Coronary Artery Slow Flow[J]. JOURNAL OF CLINICAL RESEARCH, 2020, 37(10): 1523-1525.

URL:

http://journal07.magtech.org.cn/yxlcyj/EN/10.3969/j.issn.1671-7171.2020.10.025 OR http://journal07.magtech.org.cn/yxlcyj/EN/Y2020/V37/I10/1523

[1] 张照,赵佳佳, 樊俊雅,等. 增强型体外反搏对冠状动脉慢血流患者血管内皮功能和左室舒张功能的影响[J].中国心血管杂志, 2019, 24(2):148-151.
[2] 高苓.肥厚型梗阻性心肌病患者血浆大内皮素—1水平变化及其意义[J].医学临床研究, 2019, 36(11):2206-2208.
[3] 王永.冠状动脉慢血流现象临床因素分析与内皮功能评价[J].中国介入心脏病学杂志, 2018, 26(09):42-47.
[4] 孙莉萍.冠心病合并糖耐量减低患者血小板参数与超敏 C 反应蛋白的相关性研究[J].医学临床研究, 2016, 33(3):444.
[5] 杨倩倩,崔建国,王树娟,等.冠状动脉慢血流患者的影响因素分析[J].中国循环杂志,2017,32(09):877-881.
[6] 岑锦明,杨希立,郭军,等. 冠状动脉微循环阻力指数与传统心血管危险因素、Hcy及LP-PLA₂的相关性研究[J].中国现代医学杂志, 2018, 28(33):70-76.
[7] 王文睿. 冠状动脉血流储备在冠状动脉微血管病变中的应用进展[J].中国医学影像技术, 2018, 34(11):1720-1723.
[8] Skovsted GF. Myocardial ischemia-reperfusion enhances transcriptional expression of endothelin-1 and vasoconstrictor ETB receptors via the protein kinase MEK-ERK1/2 signaling pathway in rat[J].PLoS One,2017, 12(3):1-4.
[9] 陈慧斐, 曾建平, 黄河. 经皮冠状动脉介入治疗对冠状动脉微循环阻力指数及血清高敏C反应蛋白浓度的影响[J].岭南心血管病杂志, 2018, 24(1):14-16.
[10] 李莉莉, 杨伟. 丹参酮胶囊联合贝前列素钠片治疗老年糖尿病合并颈动脉粥样硬化疗效及对血清炎性因子及内皮细胞功能的影响[J].现代中西医结合杂志, 2017, 26(22):2414-2417.
[11] 何永福. 冠状动脉慢血流现象病理生理机制及治疗进展[J].心血管病学进展, 2018, 39(3):150-154.
[12] Panakala S, Kalyan KK, Rambabu K, et al. Cystatin C as prognostic marker of coronary artery disease[J].Atherosclerosis,2017, 263(5):203-206.
[13] 陈玄祖 . 冠状动脉慢血流现象的影响因素及临床研究[J].中国循证心血管医学杂志, 2018, 10(6):108-110.